Evidence map

TrialDiabetes, obesity & metabolism2026

A Four-Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin-Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot Study.

Shawn Gugliandolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 42337820